Thomas E. Timbie, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 58,300 shares at $21.71 ($1.1M) on 2023-02-15, disclosed to the SEC on 2023-02-17.
Open-market sale of $1.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.71 | 50,000 | $1.1M | 100.0% |
| 2 | $0.00 | 8,300 | $0 | 0.0% |
| Total | $18.62 avg | 58,300 | $1.1M | 100% |
| Filing → |
| TMCI | SELL | 2022-12-16 | $1.2M | — | Filing → |
| TMCI | SELL | 2022-11-22 | $2.2M | — | Filing → |
| TMCI | SELL | 2022-11-18 | $1.0M | — | Filing → |